UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 41.

Mach, F; Gabay, C; Buchs, N; Dudler, J; Gencer, B; Hasler, P; Matter, C; Michel, B A; von Kempis, J; Zufferey, P (2015). Consensus guidelines on the cardiovascular risk management in patients with rheumatoid arthritis. Cardiovascular Medicine, 4(18):127-133.

Karouzakis, E; Rengel, Y; Jüngel, A; Kolling, C; Gay, R E; Michel, B A; Tak, P P; Gay, S; Neidhart, M; Ospelt, C (2011). DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts. Genes and Immunity, 12(8):643-652.

Trenkmann, M; Brock, M; Gay, R E; Kolling, C; Speich, R; Michel, B A; Gay, S; Huber, L C (2011). Expression and function of EZH2 in synovial fibroblasts: epigenetic repression of the Wnt inhibitor SFRP1 in rheumatoid arthritis. Annals of the Rheumatic Diseases, 70(8):1482-1488.

Kyburz, D; Gabay, C; Michel, B A; Finckh, A (2011). The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study. Rheumatology, 50(6):1106-1110.

Maciejewska Rodrigues, H; Karouzakis, E; Strietholt, S; Hemmatazad, H; Neidhart, M; Ospelt, C; Gay, R E; Michel, B A; Pap, T; Gay, S; Jüngel, A (2010). Epigenetics and rheumatoid arthritis: The role of SENP1 in the regulation of MMP-1 expression. Journal of Autoimmunity, 35(1):15-22.

Jüngel, A; Ospelt, C; Lesch, M; Thiel, M A; Sunyer, T; Schorr, O; Michel, B A; Gay, R E; Kolling, C; Flory, C; Gay, S; Neidhart, M (2010). Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis. Annals of the Rheumatic Diseases, 69(5):898-902.

Ospelt, C; Mertens, J C; Jüngel, A; Brentano, F; Maciejewska Rodrigues, H; Huber, L C; Hemmatazad, H; Wüest, T; Knuth, A; Gay, R E; Michel, B A; Gay, S; Renner, C; Bauer, S (2010). Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism, 62(5):1224-1235.

Strobel, K; Fischer, D R; Tamborrini, G; Kyburz, D; Stumpe, K D M; Hesselmann, R G X; Johayem, A; von Schulthess, G K; Michel, B A; Ciurea, A (2010). 18F-fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitis. European Journal of Nuclear Medicine and Molecular Imaging, 37(9):1760-1765.

Maciejewska Rodrigues, H; Al-Shamisi, M; Hemmatazad, H; Ospelt, C; Bouton, M C; Jäger, D; Cope, A P; Charles, P; Plant, D; Distler, J H W; Gay, R E; Michel, B A; Knuth, A; Neidhart, M; Gay, S; Jüngel, A (2010). Functional autoantibodies against serpin E2 in rheumatoid arthritis. Arthritis and Rheumatism, 62(1):93-104.

Maurer, B; Stanczyk, J; Jüngel, A; Akhmetshina, A; Trenkmann, M; Brock, M; Kowal-Bielecka, O; Gay, R E; Michel, B A; Distler, J H W; Gay, S; Distler, O (2010). MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis and Rheumatism, 62(6):1733-1743.

Tamborrini, G; Distler, O; Schmet, M; Michel, B A (2010). Mixed crystal-induced arthropathy--a rare finding. Clinical and Experimental Rheumatology, 28(5):801.

Michel, B A; Tschumi, U; Woolf, A D; Zeidler, H; Beglinger, C; Dalvit, G; Felder, M; Graf, A; Steurer, J (2009). Chronische muskuloskelettale Schmerzen in der Schweiz: Die Betreuungsqualität aus Sicht der Ärzte und der Patienten. Praxis, 98(17):933-940.

Brock, M; Trenkmann, M; Gay, R E; Michel, B A; Gay, S; Fischler, M; Ulrich, S; Speich, R; Huber, L C (2009). Interleukin-6 Modulates the Expression of the Bone Morphogenic Protein Receptor Type II Through a Novel STAT3-microRNA Cluster 17/92 Pathway. Circulation Research, 104(10):1184-11191.

Hemmatazad, H; Maciejewska Rodrigues, H; Maurer, B; Brentano, F; Pileckyte, M; Distler, J H W; Gay, R E; Michel, B A; Gay, S; Huber, L C; Distler, O; Jüngel, A (2009). Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis. Arthritis and Rheumatism, 60(5):1519-1529.

Karouzakis, E; Gay, S; Michel, B A; Gay, R E; Neidhart, M (2009). DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism, 60(12):3613-3622.

Neidhart, M; Baraliakos, X; Seemayer, C; Zelder, C; Gay, R E; Michel, B A; Boehm, H; Gay, S; Braun, J (2009). Expression of cathepsin K and MMP-1 indicate persistent osteodestruktive activity in longstanding ankylosing spondylitis. Annals of the Rheumatic Diseases, 68(8):1334-1339.

Ospelt, C; Brentano, F; Jüngel, A; Rengel, Y; Kolling, C; Michel, B A; Gay, R E; Gay, S (2009). Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism, 60(2):355-363.

Kurowska-Stolarska, M; Distler, J H; Jüngel, A; Rudnicka, W; Neumann, E; Pap, T; Wenger, R H; Michel, B A; Müller-Ladner, U; Gay, R E; Maslinski, W; Gay, S; Distler, O (2009). Inhibitor of DNA binding/differentiation 2 induced by hypoxia promotes synovial fibroblast-dependent osteoclastogenesis. Arthritis and Rheumatism, 60(12):3663-3675.

Maurer, B; Busch, N; Jüngel, A; Pileckyte, M; Gay, R E; Michel, B A; Schett, G; Gay, S; Distler, J; Distler, O (2009). Transcription factor Fos-Related Antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis. Circulation, 120(23):2367-2376.

Reisch, N; Engler, A; Aeschlimann, A; Simmen, B R; Michel, B A; Gay, R E; Gay, S; Sprott, H (2008). DREAM is reduced in synovial fibroblasts of patients with chronic arthritic pain: is it a suitable target for peripheral pain management? Arthritis Research & Therapy, 10(3)::1-8.

Huber, L C; Künzler, P; Boyce, S H; Michel, B A; Gay, R E; Ink, B S; Gay, S (2008). Effects of a novel tyrosine kinase inhibitor in rheumatoid arthritis synovial fibroblasts. Annals of the Rheumatic Diseases, 67(3):389-394.

Bachmann, S; Eisenring, M; Kool, J; Oesch, P; Michel, B A; Knüsel, O (2008). Rehabilitations- und Folgekosten bei Patienten mit chronischen Rückenschmerzen: Eine Krankheitskostenanalyse am Beispiel des Ergonomie trainingsprogramms der Klinik für Rheumatologie und Rehabilitation des Bewegungsapparates des Rehabilitationszentrums Klinik Valens, Schweiz. Physikalische Medizin, Rehabilitationsmedizin, Kurortmedizin, 18:181-188.

Ospelt, C; Kurowska-Stolarska, M; Neidhart, M; Michel, B A; Gay, R E; Laufer, S; Gay, S (2008). The dual inhibitor of lipoxygenase and cyclooxygenase ML3000 decreases the expression of CXCR3 ligands. Annals of the Rheumatic Diseases, 67(4):524-529.

Guiducci, S; Distler, J H W; Jüngel, A; Huscher, D; Huber, L C; Michel, B A; Gay, R E; Pisetsky, D S; Gay, S; Matucci-Cerinic, M; Distler, O (2008). The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis and Rheumatism, 58(9):2845-2853.

Oswald, J; Salemi, S; Michel, B A; Sprott, H (2008). Use of the Short-Form-36 Health Survey to detect a subgroup of fibromyalgia patients with psychological dysfunction. Clinical Rheumatology, 27(7):919-921.

Huber, L C; Distler, J H W; Moritz, F; Hemmatazad, H; Hauser, T; Michel, B A; Gay, R E; Matucci-Cerinic, M; Gay, S; Distler, O; Jüngel, A (2007). Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. Arthritis and Rheumatism, 56(8):275-264.

Goerres, G W; Frey, D; Hany, T F; Seifert, Burkhardt; Häuselmann, H J; Studer, A; Hauser, D; Zilic, N; Michel, B A; Hans, D; Uebelhart, D (2007). Digital X-ray radiogrammetry better identifies osteoarthritis patients with a low bone mineral density than quantitative ultrasound. European Radiology, 17(4):965-974.

Huber, L C; Jüngel, A; Distler, J H W; Moritz, F; Gay, R E; Michel, B A; Pisetsky, D S; Gay, S; Distler, O (2007). The role of membrane lipids in the induction of macrophage apoptosis by microparticles. Apoptosis, 12(2):363-374.

Distler, J H W; Jüngel, A; Huber, L C; Schulze-Horsel, U; Zwerina, J; Gay, R E; Michel, B A; Hauser, T; Schett, G; Gay, S; Distler, O (2007). Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis and Rheumatism, 56(1):311-322.

Sprott, H; Gay, R E; Michel, B A; Gay, S (2006). Influence of ibuprofen-arginine on serum levels of nitric oxide metabolites in patients with chronic low back pain--a single-blind, placebo controlled pilot trial (ISRCTN18723747). The Journal of Rheumatology, 33(12):2515-2518.

Goerres, G W; Häuselmann, H J; Seifert, Burkhardt; Michel, B A; Uebelhart, D (2005). Patients with knee osteoarthritis have lower total hip bone mineral density in the symptomatic leg than in the contralateral hip. Journal of Clinical Densitometry, 8(4):484-487.

Distler, J H W; Jüngel, A; Huber, L C; Seemayer, C A; Reich, C F; Gay, R E; Michel, B A; Fontana, A; Gay, S; Pisetsky, D S; Distler, O (2005). The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 102(8):2892-2897.

Joos, B; Uebelhart, D; Michel, B A; Sprott, H (2004). Influence of an outpatient multidisciplinary pain management program on the health-related quality of life and the physical fitness of chronic pain patients. Journal of Negative Results in BioMedicine, 3:1.

Seemayer, C A; Kolb, S A; Neidhart, M; Ohshima, S; Gay, R E; Michel, B A; Gay, S; Böni, J; Schüpbach, J (2002). Absence of inducible retroviruses from synovial fibroblasts and synovial fluid cells of patients with rheumatoid arthritis. Arthritis and Rheumatism, 46(16):2811-2813.

Distler, O; Del Rosso, A; Giacomelli, R; Cipriani, P J; Conforti, M L; Guiducci, S G; Gay, R E; Michel, B A; Brühlmann, P; Müller-Ladner, U; Gay, S; Matucci-Cerinic, M (2002). Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Research, 4(6):R11-10.

Masuda, K; Masuda, R; Neidhart, M; Simmen, B R; Michel, B A; Müller-Ladner, U; Gay, R E; Gay, S (2002). Molecular profile of synovial fibroblasts in rheumatoid arthritis depends on the stage of proliferation. Arthritis Research, 4:R8.

Eyrich, G K; Langenegger, T; Bruder, E; Sailer, H F; Michel, B A (2000). Diffuse chronic sclerosing osteomyelitis and the synovitis, acne, pustolosis, hyperostosis, osteitis (SAPHO) syndrome in two sisters. International Journal of Oral and Maxillofacial Surgery, 29(1):49-53.

Stoll, T; Huber, E; Seifert, Burkhardt; Michel, B A; Stucki, G (2000). Maximal isometric muscle strength: normative values and gender-specific relation to age. Clinical Rheumatology, 19(2):105-113.

Häuselmann, H J; Caravatti, M; Seifert, Burkhardt; Wang, K; Bruckner, P; Stucki, G; Michel, B A (1998). Can collagen type II sustain a methotrexate-induced therapeutic effect in patients with long-standing rheumatoid arthritis? A double-blind, randomized trial. British Journal of Rheumatology, 37(10):1110-1117.

Häuselmann, H J; Renfer, K; Seifert, Burkhardt; Brühlmann, P; Seitz, J; Ruetschi, C; Michel, B A (1998). Skin bioengineering methods in the monitoring of scleroderma. Current Problems in Dermatology, 26:134-44.

Theiler, R; Stucki, G; Schütz, R; Hofer, H; Seifert, Burkhardt; Tyndall, A; Michel, B A (1996). Parametric and non-parametric measures in the assessment of knee and hip osteoarthritis: interobserver reliability and correlation with radiology. Osteoarthritis and Cartilage, 4(1):35-42.

This list was generated on Fri Jul 21 05:43:02 2017 CEST.